Spotlight on Sjögren’s is a new international real-world study that explores the lived experiences of 1,155 people with Sjögren’s disease. Developed in collaboration with the patient community and supported by Novartis, the study aims to better understand the burden of the disease, unmet needs, and treatment satisfaction from a patient-centered perspective.
Presented at EULAR 2025, the findings highlight:
- The physical and emotional impact of the disease on daily life (Abstract 761)
- Low satisfaction with current therapies and a mismatch between physician and patient treatment goals (Abstract 774)
These materials are publicly accessible and compliant with EFPIA and EULAR communication guidelines. Below, you can find the informative leaflet and links to the official abstracts.
The information provided on this webpage is intended for educational and disease awareness purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. The content presented is based on research sponsored by Novartis in collaboration with various partners. Always seek the advice of your physician or other qualified health professionals with any questions you may have regarding a medical condition.